The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

According to the survey cited by NCPA, 60.4% of independent pharmacists are considering not stocking one or more of the first ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

Soon, the Centers for Medicare and Medicaid Services will begin the price negotiation process on a new set of 15 drugs. The new Trump administration should seize the opportunity to change the ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.